Jay S. Duker, MD, has been appointed as CEO of EyePoint Pharmaceuticals, and Nancy S. Lurker has transitioned from CEO to executive vice chair of the board of directors, according to a press release.
Duker joined EyePoint in 2016 as an independent member of the company’s board of directors and transitioned to part-time chief strategic scientific officer in 2020, followed by full-time chief operating officer in 2021. He assumed the role of president earlier this year.
“I am honored to become chief executive officer of EyePoint at this exciting juncture (Read more...)